This post was originally published on this site
AbbVie sees FY 2024 EPS of $11.05-$11.25 versus the analyst consensus of $11.24.
AbbVie’s stock price closed at $167.59. It is up 18.69% in the last 3 months and up 15.42% in the last 12 months.
AbbVie saw 3 positive EPS revisions and 14 negative EPS revisions in the last 90 days. See AbbVie’s stock price’s past reactions to earnings here.
According to InvestingPro, AbbVie’s Financial Health score is “great performance“.
Check out AbbVie’s recent earnings performance, and AbbVie’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
